BridgeBio Pharma, Inc. Appoints Eli Wallace As Chief Scientific Officer In Residence For Oncology Programs

Monday, December 9, 2019 1 min read

Key Takeaway: BridgeBio Pharma, Inc. Appoints Eli Wallace As Chief Scientific Officer In Residence For Oncology Programs

Full Press Release Details

BridgeBio Pharma, Inc. Appoints Eli Wallace As Chief Scientific Officer In Residence For Oncology Programs.